Literature DB >> 19394827

What lies beneath the tent? JC-virus cerebellar granule cell neuronopathy complicating sarcoidosis.

Ron Granot1, Richard Lawrence, Michael Barnett, Lynette Masters, Michael Rodriguez, Con Theocharous, Roger Pamphlett, Mark Hersch.   

Abstract

A 49-year-old, HIV-negative woman with sarcoidosis presented with a subacute unilateral cerebellar syndrome. A brain MRI revealed a hyperintense lesion without mass effect in the left cerebellar hemisphere, but no pathology above the tentorium. Steroid therapy for presumed neurosarcoidosis was ineffective and the patient deteriorated progressively. Cerebellar biopsy showed abnormal granule cells and demyelination. Immunocytochemistry confirmed the diagnosis of progressive multifocal leucoencephalopathy (PML) with JC (John Cunningham) virus granule cell neuronopathy. The patient succumbed to progressive brainstem dysfunction despite treatment with cidofovir. Although rare, PML should be considered in all patients with impaired cell-mediated immunity and unexplained neurological dysfunction, even in the absence of HIV infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19394827     DOI: 10.1016/j.jocn.2008.07.091

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  10 in total

Review 1.  Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.

Authors:  Chen S Tan; Igor J Koralnik
Journal:  Lancet Neurol       Date:  2010-04       Impact factor: 44.182

2.  JC virus granule cell neuronopathy is associated with VP1 C terminus mutants.

Authors:  Xin Dang; Jose E Vidal; Augusto C Penalva de Oliveira; David M Simpson; Susan Morgello; Jonathan H Hecht; Long H Ngo; Igor J Koralnik
Journal:  J Gen Virol       Date:  2011-09-21       Impact factor: 3.891

Review 3.  Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain.

Authors:  Michael W Ferenczy; Leslie J Marshall; Christian D S Nelson; Walter J Atwood; Avindra Nath; Kamel Khalili; Eugene O Major
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

Review 4.  Novel syndromes associated with JC virus infection of neurons and meningeal cells: no longer a gray area.

Authors:  Dhanashri P Miskin; Igor J Koralnik
Journal:  Curr Opin Neurol       Date:  2015-06       Impact factor: 5.710

5.  Gone over to the dark side: Natalizumab-associated JC virus infection of neurons in cerebellar gray matter.

Authors:  Xin Dang; Igor J Koralnik
Journal:  Ann Neurol       Date:  2013-10       Impact factor: 10.422

6.  JC virus granule cell neuronopathy in the setting of chronic lymphopenia treated with recombinant interleukin-7.

Authors:  David N Soleimani-Meigooni; Katherine E Schwetye; Maria Reyes Angeles; Caroline F Ryschkewitsch; Eugene O Major; Xin Dang; Igor J Koralnik; Robert E Schmidt; David B Clifford; F Matthew Kuhlmann; Robert C Bucelli
Journal:  J Neurovirol       Date:  2016-07-15       Impact factor: 2.643

7.  Dual therapy with cidofovir and mirtazapine for progressive multifocal leukoencephalopathy in a sarcoidosis patient.

Authors:  Jae Hyun Park; Sookyung Ryoo; Hyun Jin Noh; Jung Min Seo; Hyun Hee Kang; Ji Soo Shin; Sang Won Seo; Duk L Na
Journal:  Case Rep Neurol       Date:  2011-10-14

Review 8.  Heterogeneous imaging characteristics of JC virus granule cell neuronopathy (GCN): a case series and review of the literature.

Authors:  Martijn T Wijburg; Bob W van Oosten; Jean-Luc Murk; Ouafae Karimi; Joep Killestein; Mike P Wattjes
Journal:  J Neurol       Date:  2014-10-09       Impact factor: 6.682

9.  Cerebellar Dysfunction in a Patient with HIV.

Authors:  Fernando Gonzalez-Ibarra; Waheed Abdul; Sahar Eivaz-Mohammadi; Christopher Foscue; Srinivas Gongireddy; Amer Syed
Journal:  Case Rep Neurol Med       Date:  2014-06-30

10.  Concomitant granule cell neuronopathy in patients with natalizumab-associated PML.

Authors:  Martijn T Wijburg; Dorine Siepman; Jeroen J J van Eijk; Joep Killestein; Mike P Wattjes
Journal:  J Neurol       Date:  2016-01-25       Impact factor: 4.849

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.